Fig. 1 (abstract P338).
From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Enoblituzumab binds B7-H3 with high affinity and specificity
Fig. 1 (abstract P338). | Journal for ImmunoTherapy of Cancer